Assessing coronary heart disease in women

Maturitas

Volumn 62, Issue 3, 2009, Pages 243-247

  Rollini, F ^a   Mfeukeu, L ^a   Modena, M G ^a  

^a Institute of Cardiology   (Italy)

Author keywords

Coronary angiography; Coronary heart disease; Diagnostic tests; Risk factor; Women

Indexed keywords

CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEX DIFFERENCE;

CORONARY DISEASE; FEMALE; HEART FUNCTION TESTS; HUMANS; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 63149122265     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.013     Document Type: Review

References (36)

1. Mosca L., Jones W.K., King K.B., et al. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med 9 (2000) 506-515
2. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289 1 (2003) 76-79
3. Rosamond W., Flegal K., Friday G., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 5 (2007) 69-171
4. Kannel W.B. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med 5 (2002) 27-37
5. Ford E.S., Mokdad A.H., Giles W.H., et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 108 21 (2003) e152
6. Wexler D.J., Grant R.W., Meigs J.B., et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28 3 (2005) 514-520
7. Bolego C., Poli A., and Paoletti R. Smoking and gender. Cardiovasc Res 53 (2002) 568-576
8. Shaw L.J., Bairey Merz C.N., Pepine C.J., et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47 Suppl. 1 (2006) S4-S20
9. Albert M.A., Glynn N.J., Buring J., et al. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
10. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
11. American Autoimmune Related Diseased Association. Autoimmune disease in women: the facts, available at: http://www.aarda.org/women.php.
12. Arant C.B., Wessel T.R., Olson M.B., et al. National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study. J Am Coll Cardiol 43 (2004) 2009-2014
13. Rossi R., Chiurlia E., Modena M.G., et al. Flow-mediated vasodilation and the risk of developing hypertension in postmenopausal women. J Am Coll Cardiol 44 8 (2004) 1636-1640
14. Rossi R., Nuzzo A., and Modena M.G. Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women. Diabetes Care 28 (2005) 702-707
15. Modena M.G., Coppi F., Rossi R., et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 40 3 (2002) 505-510
16. Kinder L.S., Carnethon M.R., Palaniappan L.P., et al. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination survey. Psychosom Med 66 (2004) 316-322
17. De Backer G., Ambrosioni E., Borch-Johnsen K., et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 24 (2003) 1601-1610
18. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
19. Milner K.A., Funk M., Arnold A., et al. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J 143 (2002) 283-288
20. Harvard Medical School website, www.harvard.health.edu.
21. Johnson B.D., Shaw L.J., Buchtal S., et al. Myocardial ischemia in symptomatic women in the absence of obstructive coronary disease-prognosis and cost: results from the NIH-NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 2993-2999
22. Modena M.G., Nuzzo A., Rossi R., et al. Gender differences in diagnostic procedures. Ital Heart J 4 8 (2003) 518-521
23. Douglas P.S. Is non invasive testing for coronary artery disease accurate?. Circulation 95 (1997) 299-302
24. Picano E. Stress echocardiography: a historical perspective. Am J Med 114 (2003) 126-130
25. Mieres J.H., Shaw L.J., Hendel R.C., et al. American Society of Nuclear Cardiology: task force on women and coronary artery disease. J Nucl Cardiol 10 (2003) 95-101
26. Taillefer R., DePuey E.G., Udelson J.E., et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 29 (1997) 69-77
27. Panting J.R., Gatehouse P.D., Yang G.Z., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346 (2002) 1948-1953
28. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Non invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 (1999) 763-770
29. Buchthal S.D., Den Hollander J.A., Hee-Won K., et al. Metabolic evidence of myocardial ischemia by 31-P NMR spectroscopy in women with chest pain by no significant coronary stenoses: pilot phase results from the NHLBI WISE study. N Engl J Med 342 (2000) 829-835
30. Haberl R., Becker A., Leber A., et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol 37 (2001) 451-457
31. Raggi P., Shaw L.J., Berman D.S., et al. Gender-based differences in the prognostic value of coronary calcification. J Womens Health (Larchmt) 13 (2004) 273-278
32. O'Connor G.T., Morton J.R., Diehl M.J., et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation 88 (1993) 2104-2110
33. Kelsey S.F., James M., Holubkov A.L., et al. Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 National Heart, Lung and Blood Institute's Coronary Angioplasty Registry. Circulation 87 (1993) 720-727
34. Jacobs A.K., Kelsey S.F., Brooks M.M., et al. Better outcome for women compared with men undergoing coronary revascularization. A report from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 98 (1998) 1279-1285
35. Jacobs A.K., Johnston J.M., Haviland A., et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol 39 (2002) 1606-1614
36. Cho L., Topol E.J., Balog C., et al. Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. J Am Coll Cardiol 36 (2000) 381-386